Urogen Pharma (URGN)
(Delayed Data from NSDQ)
$15.00 USD
+0.04 (0.27%)
Updated Mar 28, 2024 04:00 PM ET
After-Market: $14.98 -0.02 (-0.13%) 7:14 PM ET
4-Sell of 5 4
F Value B Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: -- |
3/2024 | $-0.93 | -3.39% |
Earnings Summary
For their last quarter, Urogen Pharma (URGN) reported earnings of -$0.72 per share, missing the Zacks Consensus Estimate of -$0.67 per share. This reflects a negative earnings surprise of 7.46%. Look out for URGN's next earnings release expected on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.93 per share, reflecting a year-over-year increase of 28.46%.
Earnings History
Price & Consensus
Zacks News for URGN
Nurix Therapeutics, Inc. (NRIX) Surges 5.1%: Is This an Indication of Further Gains?
URGN: What are Zacks experts saying now?
Zacks Private Portfolio Services